Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Plasticell Signs Deal with JCR Pharmaceuticals

Published: Tuesday, February 25, 2014
Last Updated: Monday, February 24, 2014
Bookmark and Share
Collaboration agreement to use CombiCult® stem cell technology in Japan.

Plasticell has announced that it has signed a collaboration agreement with JCR Pharmaceuticals Co., Ltd. of Ashiya, Hyogo Pref., Japan, to discover custom stem cell culture media using its award-winning combinatorial stem cell technology, CombiCult®.

Under the terms of the agreement, Plasticell will use its stem cell expertise to work with JCR scientists, deploying CombiCult® to discover novel GMP-ready protocols for therapeutic applications. Financial terms of the agreement were not disclosed.

“Plasticell’s core capability to provide customers with optimized serum- and xeno-free GMP-grade stem cell differentiation or expansion protocols, which exclude patented factors and contain small molecule substitutes, together with the knowledge we have accumulated from a decade of differentiating all types of stem cells into a multitude of different cell types, has great potential to enhance the competitiveness of the Japanese stem cell effort,” remarked Dennis Saw, Chief Executive of Plasticell.

Saw continued, “The attractiveness of our technology is evidenced by this timely collaboration with JCR, the leading Japanese pharma in the stem cell field.”

“Plasticell’s CombiCult® is a unique technology which enables us to speed up our R&D effort, potentially contributing to reducing cost, project risk and time to market for our products,” commented Dr. Tachibana, General Manager at JCR’s Research Division.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Plasticell Appoints Dr Aaron T. T. Chuang as Chief Scientific Officer
New appointment further strengthens the company’s expertise in regenerative medicine product development.
Tuesday, June 16, 2015
Plasticell Wins Innovate UK Funding
Funding for £1.6 million cord blood stem cell manufacturing project.
Friday, February 06, 2015
Additional Family of CombiCult® Patents Granted in USA, Europe, Australia and Singapore
Newly granted patents cover the use of nanomaterial tags.
Tuesday, November 19, 2013
Plasticell and EMD Millipore Complete Licensing Deal
Deal to distribute fully defined, xeno-free mesenchymal stem cell differentiation media.
Tuesday, January 01, 2013
Plasticell and Veritas Announce an Exclusive Distribution Agreement in Japan
Veritas engaged as exclusive distributor for Plasticell’s services and products, including CombiCult®.
Monday, June 18, 2012
Plasticell Announces Grant of Fundamental CombiCult™ Patents in USA and Japan
Patents have now been issued in Europe, USA, Japan, Australia and Singapore.
Tuesday, February 14, 2012
Plasticell Wins Further Funding for Stem Cell Manufacturing Project
Technology Strategy Board will provide a grant of approximately £750k towards a £1.5m project.
Wednesday, December 14, 2011
Plasticell Delivers Differentiation Protocols to Stemnion, Inc.
Plasticell announces successful completion of a collaboration with Stemnion, Inc..
Tuesday, August 09, 2011
Plasticell Spins Out Regenerative Drug Discovery Venture
New demerged business called ‘Progenitor Labs’.
Thursday, April 14, 2011
Plasticell Completes £3.5 Million Financing Round
Capital injection to expand business development and marketing initiatives to increase growing customer base.
Wednesday, February 16, 2011
Plasticell Signs Technology Agreement with Sigma-Aldrich
Collaboration to produce novel turnkey solution for stem cell research.
Monday, November 29, 2010
Plasticell Signs Stem Cell Research Collaboration with UCB
Plasticell will screen UCB’s drug compound libraries using CombiCult™ technology to discover new cell signaling pathways involved in stem cell biology.
Tuesday, November 09, 2010
Plasticell Signs Collaboration with UCB
First in kind deal to partner small molecule drugs for stem cell research.
Monday, November 08, 2010
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!